Clinical Evidence Search

Clinical Evidence Search

Staats 2021: Surveys of Patient Preference for LBP Interventions
Summary
  • Study using two market research surveys of chronic pain patient preferences for LBP interventions.
  • LBP patients preferred temporary interventions to permanently implanted devices.
  • Temporary PNS was the most preferred treatment option over RFA and permanent implants.
Ilfeld 2021: Pilot RCT of PNS for Postoperative Pain
Summary
  • Multicenter RCT: 66 patients randomized to active PNS vs. sham.
  • PNS was significantly lower vs sham (p<0.001) in the first 7 days after surgery.
  • Interference of pain with emotional and physical functioning was reduced with PNS.
Shaw 2021: PNS for Post-thoracotomy Intercostal Pain Case Reports
Summary
  • Two reports of durable relief (13-14 months) following 60-day PNS of intercostal nerves.
  • 60-Day PNS of intercostal nerves for chronic post-thoractomy intercostal neuralgia.
  • PNS may reduce opioid and nonopioid medication usage in intercostal neuralgia pain.
Deer 2021: Proposed Mechanism of Action for Percutaneous PNS
Summary
  • Discusses potential mechanisms by which PNS may provide prolonged reductions in pain.
  • Remote selective targeting with PNS may produce robust comfortable sensations in the area of pain.
  • Prolonged pain relief may occur as a reversal of maladaptive cortical plasticity driven by PNS.
Gupta 2020: Cadaveric Feasibility of Intercostal PNS Implantation
Summary
  • Cadaveric study assessing ultrasound-guided intercostal PNS implantation
  • 12 stimulators implanted between 5th and 10th ribs bilaterally between intercostal muscles
  • Average lead-to-nerve distance: 2.3 mm (SPR MicroLead) and 1.1 mm (StimRouter)
Mainkar 2020: Pilot Study in Termporary PNS in Oncologic Pain
Summary
  • Case series (n=12) demonstrates promising peripheral targets for the treatment of oncologic pain
  • Successful PNS targeting spinal nerves, brachial plexus, and peripheral nerves for oncological pain
  • Successful relief in 7 of 12 cases, with several reporting relief beyond lead removal
Gilmore 2020: PNS in Post-Amputation Pain RCT 12-mo Follow-Up
Summary
  • Placebo-controlled RCT of PNS for chronic neuropathic pain following lower extremity amputation
  • Majority had substantial reductions in pain 12 months after start of PNS, n=9
  • 60-day PNS can provide significant long-term relief of chronic pain following amputation
Gilmore 2020: 1 Year Sustained Relief with PNS in Low Back Pain
Summary
  • Case series of Percutaneous PNS of Lumbar Medial Branches for axial back pain
  • Majority had clinically substantial (≥50%) pain relief at end of treatment compared to baseline, n=9
  • Majority had clinically significant pain and/or disability reductions at 12 months after PNS, n=6
Ilfeld 2019: Feasibility of PNS in Post-TKA Pain Management
Summary
  • Prospective study: 7 subjects, femoral and sciatic PNS for post-TKA pain
  • Pain scores <4/10  in 86% of subjects and 57% discontinued opioids during the first week
  • Functional recovery: average 6MWT improvement of 26% by 12 weeks; no device-related infections
Haider 2023: Case Report of Cervical PNS in Arthritic Neck Pain
Summary
  • Patient experienced 2 years of severe chronic pain following a work-related neck injury.
  • Physical therapy and over-the-counter pain medications did not provide sufficient relief.
  • PNS targeting the nerves of the cervical spine produced 50% reduction in pain at 2 months.
Gilmore 2019: Post-Amputation Pain RCT Primary Endpoint
Summary
  • RCT of PNS in chronic neuropathic pain following lower extremity amputation.
  • Significantly greater proportion with pain relief during PNS compared to placebo (sham) control.
  • Majority had substantial reductions in pain interference and improvements in function during PNS.
Wilson 2014: Single-arm study of PNS in Shoulder Pain from SIS
Summary
  • Studied PNS for refractory shoulder pain due to subacromial impingement syndrome
  • Significant reductions in pain and pain interference relative to baseline, n=10
  • Pain reduction is maintained for at least 12 weeks after treatment